Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab

We aimed to evaluate the humoral response after the second and third doses of SARS-CoV-2 mRNA vaccine in ABO blood type incompatible kidney transplant (KT) recipients treated with rituximab. This retrospective study conducted between June 2021 and June 2022 included 131 KT recipients and 154 nontran...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamaya, Tomoko, Hatakeyama, Shingo, Yoneyama, Tohru, Tobisawa, Yuki, Kodama, Hirotake, Fujita, Takeshi, Murakami, Reiichi, Mori, Kazuyuki, Okamoto, Teppei, Yamamoto, Hayato, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Saitoh, Hisao, Narumi, Shunji, Tomita, Hirofumi, Ohyama, Chikara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497504/
https://www.ncbi.nlm.nih.gov/pubmed/37699969
http://dx.doi.org/10.1038/s41598-023-42406-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497504/
https://www.ncbi.nlm.nih.gov/pubmed/37699969
http://dx.doi.org/10.1038/s41598-023-42406-5

Ejemplares similares